by anxrn on 2/20/22, 6:08 PM with 4 comments
by Khelavaster on 2/20/22, 7:08 PM
"3 (1.2%) vs 10 (4%) 28-day in-hospital deaths...Mechanical ventilation occurred in 4 (1.7%) vs 10 (4.0%)...intensive care unit admission in 6 (2.4%) vs 8 (3.2%)" (ivermectin vs. non-ivermectin)
These authors made a huge mistake. They didn't check the odds of all these secondary differences being slanted towards ivermectin at once. A series of low-but-above-.05 P values in the same direction show correlation even more strongly than a single near-.05 P value does.
Also, the principal result is more narrowly-scoped than reported. Though within its scope, the study's accurate: When high-risk patients wait 4-7+ days since first COVID symptoms to decide to visit a clinic and for a PCR test to come back positive, ivermectin doesn't reduce "progression to severe COVID". But ivermectin nevertheless prevents many cases of secondary COVID effects in high-risk patients, like death and need for ventilator.